BOLD vs CNTX
Comparison between Boundless Bio Inc (BOLD, Company) and Context Therapeutics Inc (CNTX, Company).
Both BOLD and CNTX are from the Healthcare sector.
BOLD vs CNTX - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
Winner
BOLD
$56M
CNTX
$56M
Max Drawdown
Winner
BOLD
92.91%
CNTX
93.53%
Sharpe Ratio
Winner
BOLD
1.11
CNTX
0.20
5Y Beta
BOLD
0.93
Winner
CNTX
0.77
Industry
BOLD
Biotechnology
CNTX
Biotechnology
P/E Ratio
BOLD
-1.01
Winner
CNTX
-1.76
PEG Ratio
BOLD
N/A
CNTX
-0.54
Debt to Equity
BOLD
0.00%
CNTX
0.00%
Free Cash Flow Yield
BOLD
-84.30%
Winner
CNTX
-58.24%
BOLD vs CNTX - Historical Returns
Returns include dividend reinvestment.
1M
Winner
BOLD
-3.08%
CNTX
-9.11%
3M
Winner
BOLD
+65.79%
CNTX
-74.47%
6M
Winner
BOLD
+100.00%
CNTX
-67.28%
1Y
Winner
BOLD
+103.23%
CNTX
-28.64%
5Y(CAGR)
BOLD
N/A
CNTX
-36.41%
Max(CAGR)
BOLD
-52.63%
Winner
CNTX
-36.41%
BOLD vs CNTX - Annual Returns (2021 - 2026)
Returns include dividend reinvestment.
| Year | BOLD | CNTX |
|---|---|---|
| 2026 | +106.56% | -61.79% |
| 2025 | -56.04% | +23.53% |
| 2024 | -79.65% | -15.32% |
| 2023 | N/A | +67.63% |
| 2022 | N/A | -76.89% |
| 2021 | N/A | -47.84% |
BOLD vs CNTX Drawdown Comparison
The maximum drawdown for BOLD was -92.91%, occurring on Jun 27, 2025. This drawdown has not yet recovered.
The maximum drawdown for CNTX was -93.53%, occurring on May 4, 2023. This drawdown has not yet recovered.
The current BOLD drawdown is -82.32%. The current CNTX drawdown is -92.05%.
| Rank | BOLD | CNTX |
|---|---|---|
| #1 | -92.91% Mar 28, 2024 - Jun 27, 2025 | -93.53% Oct 25, 2021 - May 4, 2023 |
Correlation
Correlation between BOLD and CNTX is 0.09 which considered as a very weak or no correlation - the stocks move independently of each other.
0.09
-101
Select Stocks to Compare
Popular: BOLD vs SPYCNTX vs SPY
More Comparisons
Compare with similar stocks